Biotech · Private company · Providence, RI, US
Bolden Therapeutics, Inc.
Track this companyFree. Adds Bolden Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards1
- Preclinical characterization of splice-modifying antisense oligonucleotides targeting neurogenesis in human AD neural cellsFiscal year 2024 · $504.5KNIH RePORTER 1R43AG084445-01A1 · fetched Nov 12, 2026